Abstract
Cardiovascular diseases are a major cause of human death worldwide. Excessive proliferation of vascular smooth muscle cells contributes to the etiology of such diseases, including atherosclerosis, restenosis, and pulmonary hypertension. The control of vascular cell proliferation is complex and encompasses interactions of many regulatory molecules and signaling pathways. Herein, we recapitulated the importance of signaling cascades relevant for the regulation of vascular cell proliferation. Detailed understanding of the mechanism underlying this process is essential for the identification of new lead compounds (e.g., natural products) for vascular therapies.
Full text of the study can be accessed at the website of the publisher (journal subscription is needed), or can be supplied on demand by email request to a.atanasov.mailbox@gmail.com
Reference
Wang D, Uhrin P, Mocan A, Waltenberger B, Breuss JM, Tewari D, Mihaly-Bison J, Huminiecki Ł, Starzyński RR, Tzvetkov NT, Horbańczuk J, Atanasov AG. Vascular smooth muscle cell proliferation as a therapeutic target. Part 1: molecular targets and pathways. Biotechnol Adv. 2018 Nov 1;36(6):1586-1607. doi: 10.1016/j.biotechadv.2018.04.006. Epub 2018 Apr 21. Review. PubMed PMID: 29684502.
Keywords: vascular cell proliferation, vascular smooth muscle cells (VSMC), atherosclerosis, cardiovascular diseases, antiproliferative therapies, antiproliferative agents,cell cycle, VSMC proliferation, VSMC cell division, pulmonary hypertension, restenosis, signaling pathways, molecular mechanisms, molecular targets, drug-eluting stents, anti-restenotic agents, cell signalling, signal transduction pathways.
Join for free INPST as a member
The International Natural Product Sciences Taskforce (INPST) maintains up-to-date lists with conferences, grants and funding opportunities, jobs and open positions, and journal special issues with relevance for the area of phytochemistry and food chemistry, pharmacology, pharmacognosy research, and natural product science.